Correlation between class 1 integron of Escherichia coli and multidrug resistance in lower respiratory tract infection
Class 1 integron of E. coli and multi resistance
Introduction: Class 1 integrons are mobile genetic elements considered to be responsible for the transfer of multidrug resistance. This study aimed to investigate the distribution of type 1 integrons in multidrug-resistantEscherichiacolifrom hospital-acquired lower respiratory tract infections.
Methodology: Clinical strains of E. coli were isolated from patients with hospital-acquired lower respiratory tract infections in the emergency intensive care unit from January to December 2014. Drug sensitivity testing was performed using the Kirby-Bauer method. The combination disk method was used to detect extended-spectrum β-lactamase (ESBL), and polymerase chain reaction (PCR) amplification was used to detect the intI1 gene.
Results: Among 58 E. coli strains, resistance to β-lactam antibiotics ranked as follows: imipenem (0.0%), cefoperazone/sulbactam sodium (25.9%), ceftazidime (37.9%), and cefepime (39.7%); other β-lactam antibiotic resistance rates were all > 50%. The resistance rates to amikacin, ciprofloxacin, gentamicin, and cotrimoxazole were32.8%, 63.8%, 70.7%, and 81.0%, respectively. In total, 31 (53.4%) isolates were positive for class 1 integron and carried 4 different sizes of amplification fragments: 800, 1,600, 1,900, and 2,600 bp. Among 43 ESBL-positive isolates, 27 (62.8%) also carried class 1 integron; among 15 ESBL-negative isolates, 4 carried class 1 integron (26.7%). The positive rate for class 1 integron in ESBL-producing strains was significantly higher than that in non-ESBL-producing strains. The rates of resistance of integron-positive isolates to ceftriaxone, cefotaxime, amikacin, ciprofloxacin, and cotrimoxazole were significantly higher than those in integron-negative isolates.
Conclusions: Class 1 integrons are widely distributed in E. coli and are associated with multidrug resistance.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).